- Home
- AKTX vs MTEN Comparison
AKTX vs MTEN Comparison
Compare AKTX & MTEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AKTX
- MTEN
- Stock Information
- Founded
- AKTX N/A
- MTEN 2015
- Country
- AKTX United States
- MTEN China
- Employees
- AKTX N/A
- MTEN N/A
- Industry
- AKTX Biotechnology: Pharmaceutical Preparations
- MTEN Building Products
- Sector
- AKTX Health Care
- MTEN Industrials
- Exchange
- AKTX Nasdaq
- MTEN Nasdaq
- Market Cap
- AKTX 25.1M
- MTEN 29.3M
- IPO Year
- AKTX N/A
- MTEN 2024
- Fundamental
- Price
- AKTX $0.61
- MTEN $2.22
- Analyst Decision
- AKTX Strong Buy
- MTEN
- Analyst Count
- AKTX 2
- MTEN 0
- Target Price
- AKTX $3.30
- MTEN N/A
- AVG Volume (30 Days)
- AKTX 458.6K
- MTEN 128.2K
- Earning Date
- AKTX 11-14-2025
- MTEN 10-01-2025
- Dividend Yield
- AKTX N/A
- MTEN N/A
- EPS Growth
- AKTX N/A
- MTEN N/A
- EPS
- AKTX N/A
- MTEN N/A
- Revenue
- AKTX N/A
- MTEN $10,735,337.00
- Revenue This Year
- AKTX N/A
- MTEN N/A
- Revenue Next Year
- AKTX N/A
- MTEN N/A
- P/E Ratio
- AKTX N/A
- MTEN N/A
- Revenue Growth
- AKTX N/A
- MTEN 16.63
- 52 Week Low
- AKTX $0.57
- MTEN $1.90
- 52 Week High
- AKTX $2.45
- MTEN $26.03
- Technical
- Relative Strength Index (RSI)
- AKTX 34.50
- MTEN 23.74
- Support Level
- AKTX $0.60
- MTEN $1.98
- Resistance Level
- AKTX $0.84
- MTEN $2.50
- Average True Range (ATR)
- AKTX 0.06
- MTEN 0.67
- MACD
- AKTX -0.01
- MTEN 0.05
- Stochastic Oscillator
- AKTX 2.29
- MTEN 6.81
About AKTX Akari Therapeutics plc ADS
Akari Therapeutics PLC is an oncology company developing next-generation antibody-drug conjugates (ADCs) designed around novel, proprietary cancer-killing toxins (payloads). The company believes these novel payloads may have the potential to transform the efficacy and safety outcomes of ADCs as cancer therapies beyond options that are currently available or in development. Its lead product candidate is AKTX-101, a preclinical stage Trop2-targeting ADC that combines PH1 with the Trop2 antibody, which is expressed in the highest number of solid tumor cancer types, including lung, breast, colon and prostate.
About MTEN Mingteng International Corporation Inc. Ordinary Shares
Mingteng International Corp Inc operates as an automotive mold developer and supplier in China. It provides an extensive product lineup including casting molds for turbocharger systems, braking systems, steering and differential systems, and other automotive system parts. Besides, it also produces molds for new energy electric vehicle motor drive systems, battery pack systems, and engineering hydraulic components, which are widely used in the automobile, construction machinery, and other manufacturing industries.